On September 19th, 2021-2022, the "Listed Brand of Family Standing Drugs in China" was announced, and Shensong Yangxin Capsule developed and produced by Yiling Pharmaceutical for the treatment of arrhythmia was selected as the "Listed Brand of Family Standing Drugs in China-Cardiovascular and Cerebrovascular Drugs", which showed the brand strength and consumer popularity.
It is understood that since the brand activity of China Family Standing Drugs was first held in 2016, it has been deeply concerned and expected by the drug consumption market, and has been praised as "the vane of family standing drugs" by the industry. Based on in-depth consumer surveys, online voting results, multi-dimensional expert evaluation, etc., this activity will create a more complete and scientific guide for ordinary families to know, buy and keep good medicines.
Nourishing heart, regulating rhythm, treating arrhythmia and caring for people’s mental health
In life, many people often have symptoms such as palpitation, shortness of breath, fatigue, chest tightness, blackness, syncope, etc., but they don’t care and think it’s just a minor problem. As everyone knows, these are all "signals" of arrhythmia. If we don’t pay attention to them, it is likely to induce a series of diseases such as heart failure and even sudden death.
The data shows that one in every four people suffers from arrhythmia, which is not alarmist! We should know that our heartbeat is regular (60-100 beats /min), whether it is too fast or too slow, it belongs to arrhythmia, and we should never think that we can "sit back and relax" at a young age. Most sudden deaths of young people are caused by ventricular arrhythmia. Almost everyone will have arrhythmia in his life. Arrhythmia is also closely related to age and work pressure. The older he is, the higher his work intensity and the more nervous he is, and the incidence will increase accordingly.
Arrhythmia can be effectively prevented and controlled by self-management. As a "rhythm-regulating" drug, Shensong Yangxin Capsule has been recognized by doctors and patients. According to a large number of clinical studies, Shensong Yangxin Capsule has a unique curative effect of treating arrhythmia, which can regulate sodium, calcium and potassium cardiac ion channels that cause tachyarrhythmia, regulate cardiac autonomic nerve function, effectively treat ventricular premature beats and reduce the frequency of ventricular premature beats. Moreover, the drug can also regulate pacing current related to bradyarrhythmia, improve cardiac conduction, thus effectively raising the heart rate and filling the gap in drug treatment of bradyarrhythmia.
Evidence-based medicine is the "international gold standard" for testing efficacy.
As a family medicine, we should also pay attention to scientific basis and clinical value in order to fully care for public health and safety. Evidence-based medicine research has confirmed that Shensong Yangxin Capsule can effectively treat rapid arrhythmia such as premature beats and paroxysmal atrial fibrillation. Improve slow heart rate and treat slow arrhythmia; At the same time, it can effectively treat heart failure with premature beats, sinus bradycardia with ventricular premature beats and other complex arrhythmia, fill the gap of drugs for treating both fast and slow arrhythmia at home and abroad, and obviously relieve clinical symptoms such as palpitation, shortness of breath, fatigue, insomnia and dreaminess.
Shensong Yangxin Capsule has also carried out a number of randomized, double-blind, multi-center clinical evidence-based studies on the treatment of various arrhythmia. Its unique theoretical formula and exact clinical research results have won many national awards. The application research of Shensong Yangxin capsule in treating arrhythmia won the second prize of national scientific and technological progress in 2009, and the evidence-based research of Shensong Yangxin capsule in treating sinus bradycardia with ventricular premature beats and heart failure with ventricular premature beats won the first prize of national scientific and technological progress in 2019, which is the only highest prize in the medical and health field as an important part of the project of "Construction of Chinese medicine vein theory and its guidance for the prevention and treatment of microangiopathy".
Based on conclusive evidence and good curative effect, Shensong Yangxin Capsule was listed in National Health Commission’s Guide to Rational Use of Arrhythmia, China Expert Consensus on Ventricular Arrhythmia (2016 and 2020), Atrial Fibrillation: Current Understanding and Treatment Suggestions (2015, 2018 and 2021) and China Expert Consensus on Ventricular Arrhythmia (Basic Edition).
Pay attention to drug safety and be a reassuring drug in the hearts of the people
From "experience" to "evidence", evidence-based medicine promotes the inheritance and innovation of traditional Chinese medicine. Over the years, Shensong Yangxin Capsule has always adhered to the evidence-based approach. In the long-term clinical application process, its effectiveness and safety have been widely recognized, and a large number of clinical evidence-based evidence and practical application experience have been accumulated. Shensong Yangxin Capsule is an innovative patented Chinese medicine for arrhythmia developed under the guidance of collateral disease theory of traditional Chinese medicine. As a pure Chinese medicine preparation, it belongs to the national list of essential drugs and a class of medical insurance, and is also the first Chinese patent medicine to carry out evidence-based medicine research on arrhythmia in China.
With the improvement of living standards and the aging of the population, the incidence of arrhythmia in China is also increasing year by year. In addition to common symptoms, more than 60% patients with arrhythmia are accompanied by insomnia and dreaminess. Traditional drugs mainly treat arrhythmia by "resistance", which can’t solve the fundamental problem, and can’t improve the symptoms of palpitation, chest tightness, shortness of breath and poor sleep at the same time. Shensong Yangxin Capsule has the unique advantage of "nourishing the heart and regulating the rhythm", which breaks through the bottleneck of drug treatment, can treat arrhythmia comprehensively, effectively and safely, can block the occurrence of arrhythmia in multiple ways, links and targets, is suitable for the prevention and treatment of various arrhythmias, and is more beneficial if taken for a long time.
Since the establishment of Yiling Pharmaceutical for 30 years, it has inherited the essence, kept the integrity and innovated, systematically constructed the collateral disease theory system, and promoted the research and development of innovative drugs under the guidance of collateral disease theory. At the same time, it verified the efficacy of Shensong Yangxin Capsule and other series of drugs with modern evidence-based research, and devoted itself to explaining the efficacy of traditional Chinese medicine clearly in modern medical language, which was recognized by the public and even the world. (Kong Xinjie Yixuan)